article thumbnail

The Public Hospice Companies Most Likely to Acquire in 2024

Hospice News

After a rocky year for M&A, two of the publicly traded hospice providers are poised to pursue more deals in 2024. Based on 2023 earnings trends, The Pennant Group (NASDAQ: PNTG) and Addus HomeCare Cop. The company was among the most prolific hospice buyers last year and has established growth through acquisitions as a key strategy.

article thumbnail

How April Anthony, Investors Built New Home Health and Hospice Company VitalCaring

Hospice News

Currently, nine of the company’s locations are hospices, with more expected in the coming years. Hospice is a smaller part of what we have today, but we’re excited to make that a bigger part and bring hospice into our other operating states. My roots are in home care. “My My roots are in home care. NYSE: EHAB).

professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

4 Ways Hospices Are Pursuing Growth in 2023

Hospice News

Hospices are blazing trails toward growth, each provider with its own range of strategies. In 2023, the focus for many is to not only expand their core business but to spread further into the care continuum. By 2030, the hospice market’s total dollar value is expected to nearly double, reaching $64.7 billion, up from $34.5

2023 246
article thumbnail

Key Trends That Will Shape the Hospice Industry in 2023

Hospice News

Most hospices are sliding into 2023 between a rock and a hard place, beset by headwinds, labor shortages and questions with no easy answers. Government oversight of hospice providers will tighten during 2023. Hospices have faced ever-intensifying scrutiny from regulators in recent years. Be ready for regulation.

2023 291
article thumbnail

4 Key Trends for Hospices to Watch in 2024

Hospice News

Hospice operators in 2024 are navigating a rapidly transforming environment. The prior three years have laid the groundwork for change, particularly in the regulatory space as well as gradual migration towards value-based reimbursement and in tandem, the proliferation of business lines beyond hospice.

2024 291
article thumbnail

Why Hospice M&A Could Rebound in 2024

Hospice News

After a 2023 slump, health care dealmakers are voicing optimism for a 2024 rebound. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. The close of the years also saw some earnings stabilization among publicly traded companies. This includes the $5.4

2024 275
article thumbnail

How Hospices Can Rebrand Post-Merger, Acquisition

Hospice News

Rebranding a hospice company following a merger or acquisition is a more complex process than it may seem at first blush. While consolidation slowed in 2023, many industry observers expect a rebound in 2024, though perhaps not to the record-breaking levels seen in 2021.

Hospice 262